Press Announcements > FDA approves vaccine for use after known or suspected anthrax exposure

Press Announcements > FDA approves vaccine for use after known or suspected anthrax exposure

FDA approves vaccine for use after known or suspected anthrax exposure

The U.S. Food and Drug Administration approved a new indication for Anthrax Vaccine Adsorbed to prevent disease following suspected or confirmed exposure to anthrax bacteria. The vaccine’s new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. Anthrax disease, especially the inhalation form, is often fatal if not promptly treated. Learn More >>